Lidocaine Injection, Solution
Product Images NDC 0143-9578

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lidocaine (NDC 0143-9578). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Lidocaine Hydrochoride Injection Preserved 1)

Chemical structure of lidocaine hydrochloride, showing its aromatic ring with methyl groups and amide linkage attached to an ethyl-substituted amine and associated hydrochloride ion.*

FDA Label Image

2% 2 mL Vial X 25 February 2015 (Lidocaine Hydrochoride Injection Preserved 10)

Lidocaine HCl Injection, USP 2% (20 mg/mL) solution in a 50 mL multidose vial by Hikma Pharmaceuticals USA Inc. The label indicates 1,000 mg per 50 mL, intended for infiltration and nerve block use, not for epidural or caudal administration. It contains methylparaben as a preservative and storage instructions between 20° to 25°C.*

FDA Label Image

2% 50 mL February 2015 (Lidocaine Hydrochoride Injection Preserved 11)

Label for Lidocaine Hydrochloride Injection, USP 2% (20 mg/mL) in multiple dose vials. The label shows the product's strength (2%), active ingredient concentration (1,000 mg/50 mL), and specifies it is for infiltration and nerve block only, not for epidural or caudal use. It includes storage instructions (20° to 25°C) and mentions methylparaben as a preservative. Manufactured by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

2% 50 mL X 10 February 2015 (Lidocaine Hydrochoride Injection Preserved 12)

Label of Lidocaine Hydrochloride injection solution showing a barcode, GTIN, serial number, expiration date, and lot number. The label is from Hikma Pharmaceuticals USA Inc. and includes variable fields for GTIN, serial number, expiration date, and lot number, but does not specify the strength or volume.*

FDA Label Image

West-ward Logo (Lidocaine Hydrochoride Injection Preserved 2)

Lidocaine HCl Injection, USP 20 mg/2 mL (10 mg/mL) solution for injection, labeled for infiltration and perineural nerve block use. The label indicates it is not for epidural or caudal use. The product is distributed by Hikma Pharmaceuticals USA Inc. and comes in a 2 mL multiple dose vial.*

FDA Label Image

1% 2 mL Vial February 2015 (Lidocaine Hydrochoride Injection Preserved 3)

Lidocaine HCl Injection, USP 1% (20 mg/2 mL or 10 mg/mL) solution for infiltration and nerve block, not for epidural or caudal use. Contains methylparaben as preservative. Supplied in 25 x 2 mL multiple-dose vials. Label by Hikma Pharmaceuticals USA Inc., includes lot, expiration, NDC 0143-9579-25, storage instructions, and a note on usual dosage directions.*

FDA Label Image

1% 2 mL Vial X 25 February 2015 (Lidocaine Hydrochoride Injection Preserved 4)

Label for Lidocaine Hydrochloride Injection USP 1% (10 mg/mL) by Hikma Pharmaceuticals USA Inc., in a 30 mL multiple dose vial. The solution strength is 300 mg per 30 mL, intended for infiltration and nerve block, not for epidural or caudal use. The label includes storage instructions, usage warnings, and distributor information from West-Ward in Eatontown, NJ.*

FDA Label Image

1% 30 mL February 2015 (Lidocaine Hydrochoride Injection Preserved 5)

Lidocaine HCl Injection, USP 1% (10 mg/mL) 300 mg/30 mL solution in a multiple dose vial package of 10 x 30 mL. Label indicates use for infiltration and nerve block, not for epidural or caudal use. Contains methylparaben preservative. Manufactured by Hikma Pharmaceuticals USA Inc., stored 20° to 25°C.*

FDA Label Image

1% 30 mL X 10 February 2015 (Lidocaine Hydrochoride Injection Preserved 6)

Label for Lidocaine HCl Injection, USP 1% (10 mg/mL) solution, 50 mL multiple dose vial by Hikma Pharmaceuticals USA Inc. The label states it is sterile, nonpyrogenic, contains methylparaben as preservative, and is for infiltration and nerve block but not for epidural or caudal use. Storage instructions and dosage warnings are included.*

FDA Label Image

1% 50 mL February 2015 (Lidocaine Hydrochoride Injection Preserved 7)

Label for Lidocaine HCl Injection, USP 1% (10 mg/mL), a sterile, nonpyrogenic solution for infiltration and nerve block. Contains lidocaine HCl 10 mg/mL with methylparaben as a preservative. Pack includes ten 50 mL multiple dose vials. Manufactured by Hikma Farmacêutica in Portugal and distributed by Hikma Pharmaceuticals USA Inc. Not for epidural or caudal use.*

FDA Label Image

1% 50 mL X 10 February 2015 (Lidocaine Hydrochoride Injection Preserved 8)

Lidocaine HCl Injection, USP 2% solution with 40 mg/2 mL (20 mg/mL) concentration. The label indicates it is for infiltration and nerve block, not for epidural or caudal use. The vial contains 2 mL and is distributed by West-Ward Pharmaceuticals. Lot number and expiration date fields are present but not filled in.*

FDA Label Image

2% 2 mL Vial February 2015 (Lidocaine Hydrochoride Injection Preserved 9)

Label for Lidocaine HCl Injection USP 2% (40 mg/2 mL, 20 mg/mL) solution for injection by infiltration and nerve block, not for epidural or caudal use. Contains methylparaben as preservative. Presented in 25 vials of 2 mL multiple dose. Labeler is Hikma Pharmaceuticals USA Inc., distributed by West-Ward, Eatontown, NJ. The label includes dosage, storage instructions, and notes on sterility and preservatives.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.